Kazumori Hideaki, Ishihara Shunji, Rumi Mohammad A K, Ortega-Cava Cesar F, Kadowaki Yasunori, Kinoshita Yoshikazu
Second Department of Internal Medicine, Shimane Medical University, 89-1 Enya-cho, Izumo, Shimane 693-8501, Japan.
Am J Physiol Gastrointest Liver Physiol. 2004 Mar;286(3):G508-14. doi: 10.1152/ajpgi.00269.2003. Epub 2003 Oct 16.
For the production and vesicle storage of histamine, Enterochromaffin-like (ECL) cells express histidine decarboxylase (HDC) and vesicular monoamine transporter 2 (VMAT2). Although HDC and VMAT2 show dynamic changes during gastric ulcer healing, the control system of their expression has not been fully investigated. In the present study, we investigated the effect of transforming growth factor-alpha (TGF-alpha) and proinflammatory cytokines on HDC and VMAT2 expression in rat ECL cells. Time course changes in the expression of TGF-alpha during the healing of acetic acid-induced ulcers were studied. EGF receptor (EGFR) expression was also examined in ECL cells, whereas the direct effects of TGF-alpha and proinflammatory cytokines on HDC and VMAT2 expression in ECL cells were investigated using in vivo and in vitro models. During the process of ulcer healing, expression of TGF-alpha mRNA was markedly augmented. Furthermore, EGFR was identified in isolated ECL cells. TGF-alpha stimulated HDC and VMAT2 mRNA expression and protein production and also increased histamine release from ECL cells. Selective EGFR tyrosine kinase inhibitor tyrphostin AG1478 almost completely inhibited HDC and VMAT2 gene expression induced by TGF-alpha in vivo and in vitro. During gastric mucosal injury, TGF-alpha was found to stimulate ECL cell functions by increasing HDC and VMAT2 expression.
为了合成和储存组胺囊泡,肠嗜铬样(ECL)细胞表达组氨酸脱羧酶(HDC)和囊泡单胺转运体2(VMAT2)。尽管HDC和VMAT2在胃溃疡愈合过程中呈现动态变化,但其表达的控制系统尚未得到充分研究。在本研究中,我们研究了转化生长因子-α(TGF-α)和促炎细胞因子对大鼠ECL细胞中HDC和VMAT2表达的影响。研究了乙酸诱导的溃疡愈合过程中TGF-α表达的时间进程变化。还检测了ECL细胞中表皮生长因子受体(EGFR)的表达,而使用体内和体外模型研究了TGF-α和促炎细胞因子对ECL细胞中HDC和VMAT2表达的直接影响。在溃疡愈合过程中,TGF-α mRNA的表达明显增加。此外,在分离的ECL细胞中鉴定出了EGFR。TGF-α刺激HDC和VMAT2 mRNA的表达及蛋白质的产生,还增加了ECL细胞中组胺的释放。选择性EGFR酪氨酸激酶抑制剂 tyrphostin AG1478几乎完全抑制了TGF-α在体内和体外诱导的HDC和VMAT2基因表达。在胃黏膜损伤期间,发现TGF-α通过增加HDC和VMAT2的表达来刺激ECL细胞的功能。